Ignite Creation Date:
2024-05-06 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 2:31 PM
Study NCT ID:
NCT05356195
Status:
RECRUITING
Last Update Posted:
2024-06-13
First Post:
2022-04-07
Brief Title:
Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia TDT
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Vertex Pharmaceuticals Incorporated
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Beta-Thalassemia |
| Thalassemia |
| Genetic Diseases Inborn |
| Hematologic Diseases |
| Hemoglobinopathies |
Keywords: